Live Breaking News & Updates on Nasdaq Rckt|Page 5

Stay updated with breaking news from Nasdaq rckt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month High at $24.82

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) reached a new 52-week high during trading on Monday . The stock traded as high as $24.82 and last traded at $24.75, with a volume of 1109373 shares changing hands. The stock had previously closed at $23.42. Analysts Set New Price Targets Several analysts recently […] ....

New Zealand General , New Zealand , Gotham Makker , Stifel Nicolaus , Institutional Investors Weigh In On Rocket Pharmaceuticals , Needham Company , Insider Transactions At Rocket Pharmaceuticals , Westfield Capital Management Co , Rocket Pharmaceuticals Price Performance , Rocket Pharmaceuticals , News Ratings For Rocket Pharmaceuticals Daily , Maverick Capital Ltd , Cantor Fitzgerald , Wellington Management Group , Rocket Pharmaceuticals Company Profile , Goldman Sachs Group Inc , Canaccord Genuity Group , Rocket Pharmaceuticals Inc , Get Free Report , Genuity Group , Chardan Capital , Director Gotham Makker , Management Group , Sachs Group , Street Corp , Westfield Capital Management ,

Brokerages Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Price Target at $50.38

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has been assigned a consensus recommendation of “Buy” from the nine analysts that are currently covering the stock, Marketbeat reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have updated their coverage on the […] ....

New Zealand General , New Zealand , Stifel Nicolaus , Gotham Makker , Rocket Pharmaceuticals , Cantor Fitzgerald , Maverick Capital Ltd , Rocket Pharmaceuticals Inc , Canaccord Genuity Group , Rocket Pharmaceuticals Stock , Analyst Recommendations For Rocket Pharmaceuticals , Insider Activity At Rocket Pharmaceuticals , Goldman Sachs Group Inc , Rocket Pharmaceuticals Company Profile , News Ratings For Rocket Pharmaceuticals Daily , Wellington Management Group , Securities Exchange Commission , Institutional Trading Of Rocket Pharmaceuticals , Westfield Capital Management Co , Get Free Report , Genuity Group , Director Gotham Makker , Exchange Commission , Management Group , Sachs Group , Street Corp ,

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Buy" from Brokerages

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have issued a report on […] ....

Gotham Makker , Stifel Nicolaus , Analyst Recommendations For Rocket Pharmaceuticals , Steward Partners Investment Advisory , News Ratings For Rocket Pharmaceuticals Daily , Clearstead Advisors , Rocket Pharmaceuticals Inc , Canaccord Genuity Group , Rocket Pharmaceuticals Trading , Wells Fargo Company , Rocket Pharmaceuticals , Hedge Funds Weigh In On Rocket Pharmaceuticals , Needham Company , China Universal Asset Management Co , Advisor Group Holdings Inc , Securities Exchange Commission , Get Free Report , Marketbeat Ratings , Director Gotham Makker , Exchange Commission , Group Holdings , Partners Investment Advisory , Universal Asset Management , Wells Fargo , Get Free , Rocket Pharmaceuticals Daily ,

Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) posted its quarterly earnings data on Monday. The biotechnology company reported ($0.75) EPS for the quarter, beating analysts’ consensus estimates of ($0.81) by $0.06, Briefing.com reports. During the same quarter in the previous year, the business earned ($0.87) EPS. Rocket Pharmaceuticals Trading Down 5.0 % Shares of Rocket […] ....

Stifel Nicolaus , Gaurav Shah , Gotham Makker , Steward Partners Investment Advisory , Institutional Trading Of Rocket Pharmaceuticals , Rocket Pharmaceuticals , Insider Transactions At Rocket Pharmaceuticals , Cantor Fitzgerald , Rocket Pharmaceuticals Company Profile , News Ratings For Rocket Pharmaceuticals Daily , Advisor Group Holdings Inc , Rocket Pharmaceuticals Trading Down , Rocket Pharmaceuticals Inc , Wells Fargo Company , Canaccord Genuity Group , Life Insurance Co , Earnings History For Rocket Pharmaceuticals , Securities Exchange Commission , Get Free Report , Pharmaceuticals Trading Down , Genuity Group , Chardan Capital , Exchange Commission , Director Gotham Makker , Group Holdings , Partners Investment Advisory ,

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Bought by EFG Asset Management North America Corp.

EFG Asset Management North America Corp. raised its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 1.4% during the 2nd quarter, Holdings Channel reports. The firm owned 140,023 shares of the biotechnology company’s stock after acquiring an additional 1,968 shares during the quarter. EFG Asset Management North America Corp.’s holdings in Rocket Pharmaceuticals […] ....

United States , Stifel Nicolaus , Gaurav Shah , Gotham Makker , Steward Partners Investment Advisory , Holdings Channel , Advisor Group Holdings Inc , Securities Exchange Commission , Rocket Pharmaceuticals Inc , Rocket Pharmaceuticals , Efg Asset Management North America Corp , News Ratings For Rocket Pharmaceuticals Daily , Asset Management North America Corp , Rocket Pharmaceuticals Stock , Wells Fargo Company , Rocket Pharmaceuticals Profile , Life Insurance Co , Quarter For Rocket Pharmaceuticals , Needham Company , Clearstead Advisors , Canaccord Genuity Group , Management North America , Free Report , Group Holdings , Partners Investment Advisory , Metropolitan Life Insurance ,